Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125440232 | 12544023 | 2 | F | 20160509 | 20160811 | 20160711 | 20160815 | EXP | US-GLAXOSMITHKLINE-US2016097509 | GLAXOSMITHKLINE | 63.02 | YR | F | Y | 0.00000 | 20160815 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125440232 | 12544023 | 1 | PS | LOVAZA | OMEGA-3-ACID ETHYL ESTERS | 1 | Oral | 2 G, BID | UNKNOWN | 21654 | 2 | G | CAPSULE | BID | |||||
| 125440232 | 12544023 | 2 | SS | LOVAZA | OMEGA-3-ACID ETHYL ESTERS | 1 | Oral | 2 G, BID | 6ZP4255 | 21654 | 2 | G | CAPSULE | BID | |||||
| 125440232 | 12544023 | 3 | SS | OMEGA-3-ACID ETHYL ESTERS. | OMEGA-3-ACID ETHYL ESTERS | 1 | Oral | 2 G, BID | Y | UNKNOWN | 21654 | 2 | G | BID | |||||
| 125440232 | 12544023 | 4 | SS | OMEGA-3-ACID ETHYL ESTERS. | OMEGA-3-ACID ETHYL ESTERS | 1 | Oral | 2 G, BID | Y | 21654 | 2 | G | BID | ||||||
| 125440232 | 12544023 | 5 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
| 125440232 | 12544023 | 6 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 125440232 | 12544023 | 7 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 125440232 | 12544023 | 8 | C | HYDROCODONE | HYDROCODONE | 1 | 0 | ||||||||||||
| 125440232 | 12544023 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 125440232 | 12544023 | 10 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 125440232 | 12544023 | 11 | C | NORVASC | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 125440232 | 12544023 | 12 | C | XANAX | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 125440232 | 12544023 | 13 | C | NITROGLYCERIN. | NITROGLYCERIN | 1 | U | 0 | |||||||||||
| 125440232 | 12544023 | 14 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | U | 0 | |||||||||||
| 125440232 | 12544023 | 15 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | U | 0 | |||||||||||
| 125440232 | 12544023 | 16 | C | COCONUT OIL | COCONUT OIL | 1 | U | 0 | |||||||||||
| 125440232 | 12544023 | 17 | C | BIOTIN | BIOTIN | 1 | U | 0 | |||||||||||
| 125440232 | 12544023 | 18 | C | MAGNESIUM | MAGNESIUM | 1 | U | 0 | |||||||||||
| 125440232 | 12544023 | 19 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125440232 | 12544023 | 1 | Blood triglycerides increased |
| 125440232 | 12544023 | 3 | Blood triglycerides increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125440232 | 12544023 | HO |
| 125440232 | 12544023 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125440232 | 12544023 | Abdominal discomfort | |
| 125440232 | 12544023 | Abdominal distension | |
| 125440232 | 12544023 | Arterial therapeutic procedure | |
| 125440232 | 12544023 | Carotid artery occlusion | |
| 125440232 | 12544023 | Diarrhoea | |
| 125440232 | 12544023 | Flatulence | |
| 125440232 | 12544023 | Nausea | |
| 125440232 | 12544023 | Speech disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125440232 | 12544023 | 1 | 2013 | 0 | ||
| 125440232 | 12544023 | 2 | 20160804 | 0 | ||
| 125440232 | 12544023 | 4 | 2016 | 0 |